Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Clover Biopharmaceuticals's Total Liabilities for the quarter that ended in Dec. 2025 was HK$2,491.42 Mil.
Clover Biopharmaceuticals's quarterly Total Liabilities
declined
from Dec. 2024 (HK$2,614.77 Mil) to Jun. 2025 (HK$2,514.39 Mil) and
declined
from Jun. 2025 (HK$2,514.39 Mil) to Dec. 2025 (HK$2,491.42 Mil).
Clover Biopharmaceuticals's annual Total Liabilities
declined
from Dec. 2023 (HK$3,100.06 Mil) to Dec. 2024 (HK$2,614.77 Mil) and
declined
from Dec. 2024 (HK$2,614.77 Mil) to Dec. 2025 (HK$2,491.42 Mil).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clover Biopharmaceuticals Total Liabilities Calculation
Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.
Clover Biopharmaceuticals's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Total Liabilities of HK$2,491.42 Mil mean?
Clover Biopharmaceuticals (HKSE:02197) has a Total Liabilities of HK$2,491.42 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Clover Biopharmaceuticals and its competitors.
Is Clover Biopharmaceuticals' Total Liabilities too high?
Clover Biopharmaceuticals' current Total Liabilities is HK$2,491.42 Mil. Overall, Clover Biopharmaceuticals has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Clover Biopharmaceuticals' Total Liabilities compare to VRTX and REGN?
Clover Biopharmaceuticals' Total Liabilities of HK$2,491.42 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Clover Biopharmaceuticals and its competitors. Clover Biopharmaceuticals's current Total Liabilities is HK$2,491.42 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clover Biopharmaceuticals stock overvalued right now?
Clover Biopharmaceuticals (HKSE:02197) has a current Total Liabilities of HK$2,491.42 Mil. The current Total Liabilities is HK$2,491.42 Mil. Clover Biopharmaceuticals' overall GF Score™ is 28/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Clover Biopharmaceuticals (HKSE:02197), the current Total Liabilities is HK$2,491.42 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Clover Biopharmaceuticals Ltd is a clinical-stage biotechnology company committed to unleashing the power of vaccines to save lives and improve health around the world. The leverage the proprietary Trimer-Tag technology platform to conduct R&D for vaccines that can fulfill unmet needs, with a focus on building a respiratory vaccine franchise to reduce the burden of vaccine-preventable diseases. The Group has only one operating segment, which is the research and development, manufacturing, and commercialisation of vaccines. Geographically, the company earns revenue from Mainland China and Korea.
28GF Score
Get the complete analysis for HKSE:02197
Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02197 has been successfully added to your 
